{"id":"W4401503118","doi":"10.1016/s1470-2045(24)00338-3","title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"MSD K.K.; Merck","keywords":"Pembrolizumab; Medicine; Quality of life (healthcare); Adjuvant; Internal medicine; Oncology; Placebo; Stage (stratigraphy); Melanoma; Clinical trial; Cancer; Surgery; Immunotherapy; Alternative medicine; Pathology; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001945768,0.001792253,0.00337355,0.0004317227,0.0004286362,0.001085425,0.000959044,0.001828189,0.005275891],"category_scores_gemma":[0.001449426,0.0006629669,0.002498741,0.0003796509,0.00120368,0.001244569,0.0004804289,0.003160356,0.001104776],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000850436,"about_ca_system_score_gemma":0.0008167696,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00127116,"about_ca_topic_score_gemma":0.002468983,"domain_scores_codex":[0.9993351,0.000346093,0.00004134403,0.0001300448,0.00003996929,0.0001073581],"domain_scores_gemma":[0.999353,0.0001889225,0.0001739707,0.00005203679,0.00003362097,0.0001985355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9860314,0.002538632,0.0002099525,0.0004746818,0.0006918729,0.00001727751,0.00002742346,0.0001927924,0.001611275,0.00004226618,0.0003306902,0.007831709],"study_design_scores_gemma":[0.9563109,0.04136543,0.001124349,0.00003254173,0.0004064043,0.00001470954,0.00001392243,0.000209007,0.0002002254,0.00008451001,0.0002274284,0.00001056986],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9863934,0.007251101,0.000659997,0.0006149755,0.0006574678,0.001932684,0.000868897,0.0001253592,0.001496206],"genre_scores_gemma":[0.9876414,0.003121194,0.001165078,0.00104534,0.0004240201,0.002341039,0.0008658234,0.00002579435,0.003370329],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005275891,"threshold_uncertainty_score":0.01764965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1603378670695152,"score_gpt":0.4411800088781165,"score_spread":0.2808421418086013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}